mirtazapine has been researched along with Alcohol-Related Disorders in 3 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Alcohol-Related Disorders: Disorders related to or resulting from abuse or misuse of alcohol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bejczy, A | 1 |
| Söderpalm, B | 1 |
| Brunette, MF | 1 |
| Akerman, SC | 1 |
| Dawson, R | 1 |
| O'Keefe, CD | 1 |
| Green, AI | 1 |
| Cornelius, JR | 1 |
| Chung, T | 1 |
| Douaihy, AB | 1 |
| Kirisci, L | 1 |
| Glance, J | 1 |
| Kmiec, J | 1 |
| FitzGerald, D | 1 |
| Wesesky, MA | 1 |
| Salloum, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.[NCT02185131] | Phase 2 | 16 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial[NCT02646449] | Phase 2 | 11 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Level of drinking, as indicated by the number of drinks per day as recorded on the Timeline Follow-Back calendar. (NCT02185131)
Timeframe: 12 Weeks
| Intervention | Drinks per drinking day (Mean) |
|---|---|
| Mirtazapine | 3.5 |
| Placebo | 4.4 |
Level of depressive symptoms, as indicated by the score on the Beck Depression Inventory. The Beck Depression Inventory II scoring range is as follows: 0-13 minimal depressive symptoms, 14-19 mild depressive symptoms, 20-28 moderate depressive symptoms and 29-63 severe depressive symptoms. (NCT02185131)
Timeframe: 12 Weeks
| Intervention | Units on a scale (Mean) |
|---|---|
| Mirtazapine | 27.6 |
| Placebo | 26.1 |
Level of drinking, as indicated by the number of drinks per day as recorded on the Timeline Follow-Back calendar. (NCT02646449)
Timeframe: 12 Weeks
| Intervention | Drinks per drinking day (Mean) |
|---|---|
| Mirtazapine | 2.8 |
| Placebo | 2.0 |
Level of depressive symptoms, as indicated by the score on the Beck Depression Inventory. The Beck Depression Inventory II scoring range is as follows: 0-13 minimal depressive symptoms, 14-19 mild depressive symptoms, 20-28 moderate depressive symptoms and 29-63 severe depressive symptoms. (NCT02646449)
Timeframe: 12 Weeks
| Intervention | units on a scale (Mean) |
|---|---|
| Mirtazapine | 8.0 |
| Placebo | 3.3 |
2 trials available for mirtazapine and Alcohol-Related Disorders
| Article | Year |
|---|---|
The effects of mirtazapine versus placebo on alcohol consumption in male high consumers of alcohol: a randomized, controlled trial.
Topics: Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents, Tricyclic; Double-Blind Method; | 2015 |
Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents; Comorbidity; Depression; | 2016 |
Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents; Comorbidity; Depression; | 2016 |
Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents; Comorbidity; Depression; | 2016 |
Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents; Comorbidity; Depression; | 2016 |
1 other study available for mirtazapine and Alcohol-Related Disorders
| Article | Year |
|---|---|
An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder.
Topics: Adrenergic alpha-Antagonists; Adult; Alcohol Drinking; Alcohol-Related Disorders; Antipsychotic Agen | 2016 |